MLB Commissioner Bud Selig speaks during a news conference in New York

Bud Selig: we don’t need replay. Just look at our attendance!

52 Comments

Bud Selig spoke with the media this afternoon. John Shea reposted one of the Commissioner’s answers about expanding instant replay:

People in our sport don’t want any more. Given our attendance and everything we’re doing, we’re in the right place with instant replay.

We’ve heard Selig erroneously claim that no one wants instant replay a million times — of course people in the game want it or else they wouldn’t have included an explicit provision about it in the latest collective bargaining agreement — but this new twist is too much. Attendance shows that people are fine with instant replay? Really? As if increased attendance has anything to do with it?

It’s nonsensical, as there is no relation — or at least there should be no relation — between the public’s willingness to purchase tickets and the Commissioner’s decision to make technical improvements to the game. As a response to the specific question and as a piece of logic. it’s simply incoherent.

And now that I think about it, it’s less about an answer that makes no sense as much as it is an answer that gives away Selig’s hand: no single innovation that baseball truly takes seriously is about improving the game. It’s all about the bottom line. “Who cares if we can improve the product? People are still buying tickets!”

It’s a horribly complacent position to take.  But hey, as long as a problem in the game doesn’t hurt revenue, who cares? As long as an improvement doesn’t increase revenue, why bother?  That’s what Selig is saying here.  Find me an example in American business history where such thinking didn’t lead an industry to ruin.

Cam Bedrosian weighing surgery to remove a blood clot

ANAHEIM, CA - AUGUST 2: Pitcher Cam Bedrosian #68 of the Los Angeles Angels of Anaheim throws against the Oakland Athletics during the ninth inning at Angel Stadium of Anaheim August 2, 2016, in Anaheim, California. Angels defeated the Athletics, 5-4. (Photo by Kevork Djansezian/Getty Images)
Kevork Djansezian/Getty Images
1 Comment

Angels reliever Cam Bedrosian will take the next few days to decide whether or not to undergo surgery to remove a blood clot naer his right armpit, Mike DiGiovanna of the Los Angeles Times reports. The alternative is to treat the clot with blood-thinners and rest.

Bedrosian, 24, hasn’t pitched since blowing a save against the Athletics on August 3, shortly after he took over the closer’s role from the injured Huston Street. Bedrosian was diagnosed with flexor tendinitis in the middle finger of his throwing hand about a week later.

Overall, Bedrosian — the son of former major league closer Steve — has had an outstanding season, compiling a 1.12 ERA with a 51/14 K/BB ratio in 40 1/3 innings.

Shelby Miller will return to D-Backs’ rotation on Wednesday

PHOENIX, AZ - JULY 06:  Shelby Miller #26 of the Arizona Diamondbacks delivers a pitch during the first inning against the San Diego Padres at Chase Field on July 6, 2016 in Phoenix, Arizona.  (Photo by Jennifer Stewart/Getty Images)
Getty Images
Leave a comment

Nick Piecoro of the Arizona Republic reports that Shelby Miller will return to the Diamondbacks’ starting rotation on Wednesday to start against the Giants at AT&T Field.

Miller had an abysmal first half of the season, which included a stint on the disabled list with a finger injury caused by his follow-through. In 14 starts with the D-Backs this season, Miller put up a 7.14 ERA with a 50/34 K/BB ratio in 69 1/3 innings.

Miller was demoted to Triple-A Reno and made his first start shortly after the All-Star break. In eight starts in the minors, Miller compiled a much-improved 3.91 ERA with a 55/10 K/BB ratio in 50 2/3 innings.

The Diamondbacks acquired Miller along with minor leaguer Gabe Speier from the Braves this past winter in a heavily-criticized trade that sent Ender Inciarte, Aaron Blair, and 2015 No. 1 overall pick Dansby Swanson to Atlanta.